ClinicalTrials.gg
Sign In

Shanghai Xin Huanghe Pharmaceutical Co., Ltd. clinical trials

Acquired by Chenpon Pharmaceutical

The registry lists 3 studies whose lead sponsor is Shanghai Xin Huanghe Pharmaceutical Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 8, 2026.

What it is testing

The drugs Shanghai Xin Huanghe Pharmaceutical Co., Ltd.’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 3 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed3100%

Phase

  • Phase 31
  • Phase 21
  • Phase 11

Where

  • China3

Over the years

  1. 224
  2. 25
  3. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Shanghai Xin Huanghe Pharmaceutical Co., Ltd.3 studies

Something wrong with this grouping? Tell us on the Chenpon Pharmaceutical page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All Chenpon Pharmaceutical studies →